MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Zynerba Pharmaceuticals P/S Ratio 2011-2026 | ZYNE
Annual P/S Ratio Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 895 | - | 21.3 K | 106 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.3 K | 106 | 7.43 K |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | USA |
 |
Assertio Holdings
ASRT
|
0.635 | $ 18.95 | -1.61 % | $ 121 M | USA |
 |
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 3.07 | -0.97 % | $ 43.2 M | USA |
 |
Cronos Group
CRON
|
77.6 | $ 2.53 | -2.13 % | $ 1.32 B |  Canada |
 |
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B |  France |
 |
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
0.386 | $ 5.24 | -3.23 % | $ 1.91 B | Canada |
 |
Aurora Cannabis
ACB
|
3.73 | $ 3.36 | -2.32 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
0.528 | $ 0.98 | -3.48 % | $ 105 M | Canada |
 |
Harrow Health
HROW
|
7.1 | $ 34.58 | -1.57 % | $ 1.27 B | USA |
 |
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M |  Irlanda |
 |
Evolus
EOLS
|
0.913 | $ 3.98 | -4.45 % | $ 257 M | USA |
 |
Emergent BioSolutions
EBS
|
0.132 | $ 7.78 | -3.95 % | $ 398 M | USA |
 |
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | USA |
 |
OrganiGram Holdings
OGI
|
4.82 | $ 1.37 | -1.09 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.86 | $ 2.35 | 4.91 % | $ 309 M | USA |
 |
Pacira BioSciences
PCRX
|
5.13 | $ 22.33 | 0.25 % | $ 1.03 B | USA |
 |
Jupiter Wellness
JUPW
|
3.37 | - | - | $ 33.6 M | USA |
 |
Sundial Growers
SNDL
|
0.0158 | $ 1.33 | -0.77 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 2.22 | -4.52 % | $ 2.76 M | USA |
 |
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
1.9 | $ 6.49 | -2.63 % | $ 4.01 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | Canada |
 |
Veru
VERU
|
6.39 | $ 2.45 | 1.92 % | $ 330 M | USA |
 |
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | USA |
 |
Viatris
VTRS
|
1.19 | $ 13.28 | -1.01 % | $ 15.9 B | USA |
 |
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | USA |
 |
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
0.0863 | $ 0.7 | -4.12 % | $ 3.02 M | USA |
 |
Rockwell Medical
RMTI
|
0.488 | $ 0.95 | -1.55 % | $ 34.2 M | USA |
 |
SCYNEXIS
SCYX
|
1.84 | $ 0.96 | 5.21 % | $ 47.9 M | USA |
 |
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | USA |
 |
China Pharma Holdings
CPHI
|
0.663 | $ 0.61 | - | $ 2.62 M |  China |
 |
TherapeuticsMD
TXMD
|
7.62 | $ 2.02 | -8.18 % | $ 23.4 M | USA |